| Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis Y Zheng, DM Danilenko, P Valdez, I Kasman, J Eastham-Anderson, J Wu, ... Nature 445 (7128), 648-651, 2007 | 2418 | 2007 |
| Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival M Schwickart, XD Huang, JR Lill, J Liu, R Ferrando, DM French, ... Nature 463 (7277), 103-107, 2010 | 722 | 2010 |
| A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer F de Sousa e Melo, AV Kurtova, JM Harnoss, N Kljavin, JD Hoeck, J Hung, ... Nature 543 (7647), 676-680, 2017 | 586 | 2017 |
| Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial S Vermeire, S O'Byrne, M Keir, M Williams, TT Lu, JC Mansfield, CA Lamb, ... The Lancet 384 (9940), 309-318, 2014 | 500 | 2014 |
| Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax) JD Leverson, H Zhang, J Chen, SK Tahir, DC Phillips, J Xue, P Nimmer, ... Cell death & disease 6 (1), e1590-e1590, 2015 | 485 | 2015 |
| B‐cell activation influences T‐cell polarization and outcome of anti‐CD20 B‐cell depletion in central nervous system autoimmunity MS Weber, T Prod'Homme, JC Patarroyo, N Molnarfi, T Karnezis, ... Annals of neurology 68 (3), 369-383, 2010 | 329 | 2010 |
| DLK initiates a transcriptional program that couples apoptotic and regenerative responses to axonal injury TA Watkins, B Wang, S Huntwork-Rodriguez, J Yang, Z Jiang, ... Proceedings of the National Academy of Sciences 110 (10), 4039-4044, 2013 | 300 | 2013 |
| An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies X Ye, Y Li, S Stawicki, S Couto, J Eastham-Anderson, D Kallop, R Weimer, ... Oncogene 29 (38), 5254-5264, 2010 | 252 | 2010 |
| Therapeutic antibodies reveal Notch control of transdifferentiation in the adult lung D Lafkas, A Shelton, C Chiu, G de Leon Boenig, Y Chen, SS Stawicki, ... Nature 528 (7580), 127-131, 2015 | 227 | 2015 |
| Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1 CJ Spooner, J Lesch, D Yan, AA Khan, A Abbas, V Ramirez-Carrozzi, ... Nature immunology 14 (12), 1229-1236, 2013 | 205 | 2013 |
| FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways AL Wu, S Coulter, C Liddle, A Wong, J Eastham-Anderson, DM French, ... PloS one 6 (3), e17868, 2011 | 204 | 2011 |
| Glucagon couples hepatic amino acid catabolism to mTOR-dependent regulation of α-cell mass MJ Solloway, A Madjidi, C Gu, J Eastham-Anderson, HJ Clarke, N Kljavin, ... Cell reports 12 (3), 495-510, 2015 | 178 | 2015 |
| PlGF blockade does not inhibit angiogenesis during primary tumor growth C Bais, X Wu, J Yao, S Yang, Y Crawford, K McCutcheon, C Tan, ... Cell 141 (1), 166-177, 2010 | 178 | 2010 |
| Association between response to etrolizumab and expression of integrin αE and granzyme A in colon biopsies of patients with ulcerative colitis GW Tew, JA Hackney, D Gibbons, CA Lamb, D Luca, JG Egen, L Diehl, ... Gastroenterology 150 (2), 477-487. e9, 2016 | 162 | 2016 |
| Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancer MR Junttila, W Mao, X Wang, BE Wang, T Pham, J Flygare, SF Yu, S Yee, ... Science translational medicine 7 (314), 314ra186-314ra186, 2015 | 159 | 2015 |
| Suppression of HER2/HER3-mediated growth of breast cancer cells with combinations of GDC-0941 PI3K inhibitor, trastuzumab, and pertuzumab E Yao, W Zhou, ST Lee-Hoeflich, T Truong, PM Haverty, ... Clinical Cancer Research 15 (12), 4147-4156, 2009 | 150 | 2009 |
| Function of CSF1 and IL34 in macrophage homeostasis, inflammation, and cancer WY Lin, D Xu, CD Austin, P Caplazi, K Senger, Y Sun, S Jeet, J Young, ... Frontiers in immunology 10, 2019, 2019 | 147 | 2019 |
| MAP4K4 regulates integrin-FERM binding to control endothelial cell motility P Vitorino, S Yeung, A Crow, J Bakke, T Smyczek, K West, E McNamara, ... Nature 519 (7544), 425-430, 2015 | 141 | 2015 |
| Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells W Chen, T Tang, J Eastham-Anderson, D Dunlap, B Alicke, M Nannini, ... Proceedings of the National Academy of Sciences 108 (23), 9589-9594, 2011 | 137 | 2011 |
| Combined targeting of BRAF and CRAF or BRAF and PI3K effector pathways is required for efficacy in NRAS mutant tumors BS Jaiswal, V Janakiraman, NM Kljavin, J Eastham-Anderson, JE Cupp, ... Plos one 4 (5), e5717, 2009 | 130 | 2009 |
